A Study of BV-AVD in People With Bulky Hodgkin Lymphoma

NCT06377566 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

71

Enrollment

OTHER

Sponsor class

Conditions

Hodgkin Lymphoma

Interventions

DRUG: Brentuximab vedotin
DRUG: Doxorubicin
DRUG: Vinblastine
DRUG: Dacarbazine
DRUG: Pembrolizumab
DRUG: Gemcitabine
DRUG: Vinorelbine
DIAGNOSTIC_TEST: FDG-PET/CT scan

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]